Phase I study of ABT-199 (GDC-0199) in patients with relapsed/refractory (R/R) non-Hodgkin lymphoma (NHL): Responses observed in diffuse large B-cell (DLBCL) and follicular lymphoma (FL) at higher cohort doses Meeting Abstract


Authors: Davids, M. S.; Seymour, J. F.; Gerecitano, J. F.; Kahl, B. S.; Pagel, J. M.; Wierda, W. G.; Anderson, M. A.; Rudersdorf, N.; Gressick, L. A.; Montalvo, N. P.; Yang, J. N.; Zhu, M.; Dunbar, M.; Cerri, E.; Enschede, S. H.; Humerickhouse, R.; Roberts, A. W.
Abstract Title: Phase I study of ABT-199 (GDC-0199) in patients with relapsed/refractory (R/R) non-Hodgkin lymphoma (NHL): Responses observed in diffuse large B-cell (DLBCL) and follicular lymphoma (FL) at higher cohort doses
Meeting Title: 50th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 32
Issue: 15 Suppl.
Meeting Dates: 2014 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2014-05-20
Language: English
ACCESSION: WOS:000358613204202
PROVIDER: wos
DOI: 10.1200/jco.2014.32.15_suppl.8522
Notes: Meeting Abstract: 8522 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors